An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A

PHASE3CompletedINTERVENTIONAL
Enrollment

349

Participants

Timeline

Start Date

March 1, 2011

Primary Completion Date

June 1, 2012

Study Completion Date

June 14, 2012

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GSK 573719 +GW642444 125/25

125mcg/ 25mcg

DRUG

GSK573719 + GW642444 62.5/25

62.5mcg/25mcg

DRUG

GSK 573719 125

125mcg

DRUG

GSK 573719 62.5

62.5mcg

DRUG

GW642444 25

25mcg

DRUG

Plb

Comparator

Trial Locations (31)

1000

GSK Investigational Site, Sofia

4000

GSK Investigational Site, Plovdiv

10117

GSK Investigational Site, Berlin

10787

GSK Investigational Site, Berlin

12205

GSK Investigational Site, Albany

13619

GSK Investigational Site, Tallinn

20253

GSK Investigational Site, Hamburg

20354

GSK Investigational Site, Hamburg

22927

GSK Investigational Site, Großhansdorf

23229

GSK Investigational Site, Richmond

29303

GSK Investigational Site, Spartanburg

29340

GSK Investigational Site, Gaffney

29379

GSK Investigational Site, Union

29615

GSK Investigational Site, Greenville

42651

GSK Investigational Site, Solingen

43215

GSK Investigational Site, Columbus

44787

GSK Investigational Site, Bochum

51014

GSK Investigational Site, Tartu

58452

GSK Investigational Site, Witten

63571

GSK Investigational Site, Gelnhausen

65187

GSK Investigational Site, Wiesbaden

77339

GSK Investigational Site, Kingwood

85006

GSK Investigational Site, Phoenix

97504

GSK Investigational Site, Medford

127018

GSK Investigational Site, Moscow

197022

GSK Investigational Site, Saint Petersburg

454106

GSK Investigational Site, Chelyabinsk

03756

GSK Investigational Site, Lebanon

656 045

GSK Investigational Site, Barnaul

105 077

GSK Investigational Site, Moscow

HA6 2RN

GSK Investigational Site, Northwood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01328444 - An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A | Biotech Hunter | Biotech Hunter